{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:19Z","timestamp":1791357439906,"version":"4.3.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":2001,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Excessive daytime sleepiness in patients with obstructive sleep apnea is associated with substantial burden of illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess treatment effects of solriamfetol, a dopamine\/norepinephrine reuptake inhibitor, on daily functioning, health-related quality of life, and work productivity in participants with obstructive sleep apnea and excessive daytime sleepiness as additional outcomes in a 12-week phase 3 trial (www.clinicaltrials.gov identifier NCT02348606).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants (N\u2009=\u2009476) were randomized to solriamfetol 37.5, 75, 150, or 300 mg or to placebo. Outcome measures included the Functional Outcomes of Sleep Questionnaire short version, Work Productivity and Activity Impairment Questionnaire: Specific Health Problem, and 36-item Short Form Health Survey version 2. A mixed-effects model with repeated measures was used for comparisons with placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Demographics, baseline disease characteristics, daily functioning, health-related quality of life, and work productivity were similar across groups. At Week 12, increased functioning and decreased impairment were observed with solriamfetol 150 and 300 mg (mean difference from placebo [95% confidence interval]) on the basis of Functional Outcomes of Sleep Questionnaire total score (1.22 [0.57 to 1.88] and 1.47 [0.80 to 2.13], respectively), overall work impairment (\u221211.67 [\u221219.66 to \u22123.69] and \u221211.75 [\u221219.93 to \u22123.57], respectively), activity impairment (\u221210.42 [\u221216.37 to \u22124.47] and \u221210.51 [\u221216.59 to \u22124.43], respectively), physical component summary (2.07 [0.42 to 3.72] and 1.91 [0.22 to 3.59], respectively), and mental component summary (150 mg only, 2.05 [0.14 to 3.96]). Common adverse events were headache, nausea, decreased appetite, and anxiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Solriamfetol improved measures of functioning, quality of life, and work productivity in participants with obstructive sleep apnea and excessive daytime sleepiness. Safety was consistent with previous studies.<\/jats:p>\n                    <jats:p>Clinical trial registered with www.clinicaltrials.gov (NCT02348606).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202002-136oc","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T18:25:36Z","timestamp":1588271136000},"page":"998-1007","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":37,"title":["Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-5766","authenticated-orcid":false,"given":"Terri E.","family":"Weaver","sequence":"first","affiliation":[{"name":"University of Illinois at Chicago College of Nursing, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Drake","sequence":"additional","affiliation":[{"name":"Henry Ford Hospital Sleep Disorders and Research Center, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Benes","sequence":"additional","affiliation":[{"name":"Somni Bene Institut f\u00fcr Medizinische Forschung und Schlafmedizin Schwerin GmbH, Schwerin, Germany"},{"name":"Medical Center, University of Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stern","sequence":"additional","affiliation":[{"name":"Advanced Respiratory and Sleep Medicine, PLLC, Huntersville, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Maynard","sequence":"additional","affiliation":[{"name":"CTI Clinical Research Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Thein","sequence":"additional","affiliation":[{"name":"Pacific Research Network, Evolution Research Group, LLC, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Sr.","given":"James M.","family":"Andry","sequence":"additional","affiliation":[{"name":"Sleep Therapy & Research Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Hudson","sequence":"additional","affiliation":[{"name":"FutureSearch Trials of Neurology LP, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.","family":"Carter","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"},{"name":"University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Bron","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Lee","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed","family":"Black","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"},{"name":"Stanford Center for Sleep Sciences and Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Bogan","sequence":"additional","affiliation":[{"name":"SleepMed, Inc., Columbia, South Carolina; and"},{"name":"University of South Carolina School of Medicine, Columbia, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"2026012221294319700_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jsr.12039","article-title":"Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure","volume":"22","author":"Gasa","year":"2013","journal-title":"J Sleep Res"},{"key":"2026012221294319700_bib2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"P\u00e9pin","year":"2009","journal-title":"Eur Respir J"},{"key":"2026012221294319700_bib3","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1523\/JNEUROSCI.0857-07.2007","article-title":"Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model","volume":"27","author":"Zhu","year":"2007","journal-title":"J Neurosci"},{"key":"2026012221294319700_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/sleep\/27.2.194","article-title":"Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions","volume":"27","author":"Veasey","year":"2004","journal-title":"Sleep"},{"key":"2026012221294319700_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.5665\/sleep.3578","article-title":"Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea","volume":"37","author":"Kumar","year":"2014","journal-title":"Sleep (Basel)"},{"key":"2026012221294319700_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/sleep\/32.6.791","article-title":"Obstructive sleep apnea: a risk factor for work disability","volume":"32","author":"Omachi","year":"2009","journal-title":"Sleep"},{"key":"2026012221294319700_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/JOM.0b013e3181e12b05","article-title":"Work productivity in obstructive sleep apnea patients","volume":"52","author":"Nena","year":"2010","journal-title":"J Occup Environ Med"},{"key":"2026012221294319700_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.sleep.2007.01.009","article-title":"The impact of obstructive sleep apnea and daytime sleepiness on work limitation","volume":"9","author":"Mulgrew","year":"2007","journal-title":"Sleep Med"},{"key":"2026012221294319700_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1183\/09031936.00124708","article-title":"Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients","volume":"34","author":"Koutsourelakis","year":"2009","journal-title":"Eur Respir J"},{"key":"2026012221294319700_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpsychores.2015.01.012","article-title":"Anxiety and its relationship to quality of life independent of depression in patients with obstructive sleep apnea","volume":"79","author":"Lee","year":"2015","journal-title":"J Psychosom Res"},{"key":"2026012221294319700_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.7624","article-title":"Comorbidities, health-related quality of life, and work productivity among people with obstructive sleep apnea with excessive sleepiness: findings from the 2016 US National Health and Wellness Survey","volume":"15","author":"Stepnowsky","year":"2019","journal-title":"J Clin Sleep Med"},{"key":"2026012221294319700_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/sleep\/34.3.363","article-title":"Excessive daytime sleepiness is associated with increased health care utilization among patients referred for assessment of OSA","volume":"34","author":"Ronksley","year":"2011","journal-title":"Sleep (Basel)"},{"key":"2026012221294319700_bib13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.sleep.2010.07.010","article-title":"Sleep disorders and accidental risk in a large group of regular registered highway drivers","volume":"11","author":"Philip","year":"2010","journal-title":"Sleep Med"},{"key":"2026012221294319700_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5664\/jcsm.27662","article-title":"Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis","volume":"5","author":"Tregear","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"2026012221294319700_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5665\/sleep.5834","article-title":"Risk of occupational accidents in workers with obstructive sleep apnea: systematic review and meta-analysis","volume":"39","author":"Garbarino","year":"2016","journal-title":"Sleep (Basel)"},{"key":"2026012221294319700_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00002826-200309000-00009","article-title":"Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy","volume":"26","author":"Schwartz","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"2026012221294319700_bib17","article-title":"Provigil [package insert]","year":"2018"},{"key":"2026012221294319700_bib18","article-title":"Nuvigil [package insert]","year":"2018"},{"key":"2026012221294319700_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.5664\/jcsm.5096","article-title":"Effect of wakefulness-promoting agents on sleepiness in patients with sleep apnea treated with CPAP: a meta-analysis","volume":"11","author":"Sukhal","year":"2015","journal-title":"J Clin Sleep Med"},{"key":"2026012221294319700_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1067\/mcp.2002.121217","article-title":"Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers","volume":"71","author":"Robertson","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"2026012221294319700_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/pr.112.007054","article-title":"Psychostimulants and cognition: a continuum of behavioral and cognitive activation","volume":"66","author":"Wood","year":"2013","journal-title":"Pharmacol Rev"},{"key":"2026012221294319700_bib22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/sleep\/32.11.1425","article-title":"The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents","volume":"32","author":"Gruner","year":"2009","journal-title":"Sleep"},{"key":"2026012221294319700_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.118.248120","article-title":"Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor","volume":"366","author":"Baladi","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"2026012221294319700_bib24","article-title":"Sunosi (solriamfetol) tablets prescribing information","year":"2019"},{"key":"2026012221294319700_bib25","article-title":"Sunosi [summary of product characteristics]","year":"2020"},{"key":"2026012221294319700_bib26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","article-title":"Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3): a randomized controlled trial","volume":"199","author":"Schweitzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012221294319700_bib27","volume-title":"International classification of sleep disorders.","author":"American Academy of Sleep Medicine","year":"2014"},{"key":"2026012221294319700_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/sleep\/32.7.915","article-title":"Development of the FOSQ-10: a short version of the functional outcomes of sleep questionnaire","volume":"32","author":"Chasens","year":"2009","journal-title":"Sleep"},{"key":"2026012221294319700_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"2026012221294319700_bib30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"key":"2026012221294319700_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2026012221294319700_bib32","volume-title":"EQ-5D-5L user guide.","author":"van Reenen","year":"2015"},{"key":"2026012221294319700_bib33","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"2026012221294319700_bib34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1164\/ajrccm.159.2.9804051","article-title":"Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study","volume":"159","author":"Gottlieb","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012221294319700_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/sleep\/30.6.711","article-title":"Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning","volume":"30","author":"Weaver","year":"2007","journal-title":"Sleep"},{"key":"2026012221294319700_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(05)64601-6","article-title":"Impact of daytime sleepiness underrated","volume":"348","author":"Sharpley","year":"1996","journal-title":"Lancet"},{"key":"2026012221294319700_bib37","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/brain\/124.8.1482","article-title":"Excessive daytime sleepiness: a challenge for the practising neurologist","volume":"124","author":"Guilleminault","year":"2001","journal-title":"Brain"},{"key":"2026012221294319700_bib38","doi-asserted-by":"crossref","first-page":"A227","DOI":"10.1093\/sleep\/zsy061.611","article-title":"Using multiple anchor-based and distribution-based estimates to determine the minimal important difference (MID) for the FOSQ-10 [abstract]","volume":"41","author":"Weaver","year":"2018","journal-title":"Sleep (Basel)"},{"key":"2026012221294319700_bib39","article-title":"SF-36 health survey update","author":"Ware","year":"2006"},{"key":"2026012221294319700_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.smrv.2009.02.004","article-title":"A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome","volume":"13","author":"McDaid","year":"2009","journal-title":"Sleep Med Rev"},{"key":"2026012221294319700_bib41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5664\/jcsm.27648","article-title":"Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment","volume":"5","author":"Weaver","year":"2009","journal-title":"J Clin Sleep Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/17\/8\/998\/66545664\/annalsats_17_8_998.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/17\/8\/998\/66545664\/annalsats_17_8_998.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:30:01Z","timestamp":1769135401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/17\/8\/998\/8418809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,1]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202002-136oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"2020-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}